Sarepta Therapeutics is making some necessary changes, and the stock is responding wellBiopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The biopharmaceutical company announced a strategic restructuring plan, laying off about 500 employees -- more than a third of its workforce -- after two deaths following treatment with its gene therapy for fatal muscle disorder, Elevidys. The treatment will stay on the market with warnings about the potential for l ...